最新更新 :
06/05/2024
研究小組 - Pharmaceutical Research and Development, Pfizer Inc   PDF  
美国
製藥實驗室
Pharmaceutical Research and Development, Pfizer Inc
Andover
电子邮箱
引用文献   引用文献   (2)  
1
Physicochemical stability of PF-05280014 (trastuzumab-qyyp; TrazimeraTM), a trastuzumab biosimilar, under extended in-use conditions.
Weiser S, Burns C, Zartler E (Sarah.Weiser@pfizer.com)
J Oncol Pharm Practice - 2023 - ;29,3:
2
Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev®), a bevacizumab biosimilar, under extended in-use conditions.
Weiser S, Burns C, Zartler E. (Sarah.Weiser@pfizer.com)
J Oncol Pharm Practice - 2022 - ;29, 5: 1032-1043

药品清单   分子研究   (2)  
抗癌藥物 注射液 Bevacizumab
抗癌藥物 注射液 Trastuzumab

  Mentions Légales